Principal Financial Group Inc Covetrus, Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$20.69 - $20.91 $49,324 - $49,849	2,384 Added 0.37%	647,258 $13.5 Million
Q2 2022 Aug 10, 2022	SELL	$13.8 - $20.82 $507,522 - $765,697	-36,777 Reduced 5.4%	644,874 $13.4 Million
Q1 2022 May 09, 2022	SELL	$15.96 - $18.87 $94,642 - $111,899	-5,930 Reduced 0.86%	681,651 $11.4 Million
Q4 2021 Feb 09, 2022	SELL	$16.79 - $20.37 $266,927 - $323,842	-15,898 Reduced 2.26%	687,581 $13.7 Million
Q3 2021 Nov 09, 2021	BUY	$18.14 - $27.03 $33,522 - $49,951	1,848 Added 0.26%	703,479 $12.8 Million
Q2 2021 Aug 10, 2021	BUY	$25.24 - $30.86 $161,182 - $197,071	6,386 Added 0.92%	701,631 $18.9 Million
Q1 2021 May 10, 2021	BUY	$28.29 - $39.89 $171,776 - $242,212	6,072 Added 0.88%	695,245 $20.8 Million
Q4 2020 Feb 08, 2021	SELL	$24.45 - $31.59 $316,407 - $408,806	-12,941 Reduced 1.84%	689,173 $19.8 Million
Q3 2020 Nov 06, 2020	SELL	$17.22 - $24.59 $628,684 - $897,756	-36,509 Reduced 4.94%	702,114 $17.1 Million
Q2 2020 Aug 05, 2020	SELL	$6.46 - $19.27 $440,494 - $1.31 Million	-68,188 Reduced 8.45%	738,623 $13.2 Million
Q1 2020 May 12, 2020	SELL	$5.64 - $15.23 $171,055 - $461,910	-30,329 Reduced 3.62%	806,811 $6.57 Million
Q4 2019 Feb 05, 2020	BUY	$8.8 - $14.93 $3.73 Million - $6.32 Million	423,335 Added 102.3%	837,140 $11.1 Million
Q3 2019 Nov 13, 2019	SELL	$11.76 - $25.57 $120,857 - $262,782	-10,277 Reduced 2.42%	413,805 $4.92 Million
Q2 2019 Aug 12, 2019	BUY	$22.88 - $33.27 $63,057 - $91,692	2,756 Added 0.65%	424,082 $10.4 Million
Q1 2019 May 10, 2019	BUY	$31.52 - $46.19 $13.3 Million - $19.5 Million	421,326 New	421,326 $13.4 Million

Others Institutions Holding CVET

# of Institutions

Shares Held

72.9K

Call Options Held

Put Options Held

View Full List

About COVETRUS, INC.

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

More about CVET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account